Aravive, Inc. Common Stock
ARAV
ARAV was delisted on the 26th of January, 2024.
66 hedge funds and large institutions have $311M invested in Aravive, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 9 reducing their positions, and 13 closing their positions.
311% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 9
2% more funds holding
Funds holding: 65 → 66 (+1)
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
21% less capital invested
Capital invested by funds: $394M → $311M (-$83.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$7.75M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.97M |
| 3 |
TCP
Tourbillon Capital Partners
New York
|
+$4.98M |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$3.07M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$16.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16.2M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$8.76M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$7.07M |
| 5 |
DM
Deerfield Management
New York
|
-$6.24M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCA
76
Secor Capital Advisors
New York
| – | -$189K | -1,714 | Closed |
|
77
AllianceBernstein
Nashville,
Tennessee
| – | -$121K | -1,100 | Closed |
|
|
TRCT
78
Tower Research Capital (TRC)
New York
| – | -$10K | -90 | Closed |
|
|
HR
79
Howe & Rusling
Rochester,
New York
| – | +$507 | +5 | New |
|
ARAV Hedge Fund Activity: Q2 2015 in Review
66 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q2 2015, worth a combined $311M — down 21% from $394M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ARAV positions and 13 closed out — a net gain of 1 holder — while 37 added to existing stakes and 9 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $7.75M. The largest seller was HealthCor Management, exiting entirely with an estimated $16.9M sold.
- 66 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q2 2015, up from 65 in Q1 2015.
- Funds reported $311M of Aravive, Inc. Common Stock stock for Q2 2015, down 21% quarter-over-quarter.
- 14 funds opened new Aravive, Inc. Common Stock positions in Q2 2015 and 13 closed out, a net change of +1 holder.
- The largest Aravive, Inc. Common Stock buyer in Q2 2015 was Baker Bros. Advisors, an estimated $7.75M added.
- The largest Aravive, Inc. Common Stock seller in Q2 2015 was HealthCor Management, an estimated $16.9M sold.
Based on aggregated 13F filings for Q2 2015.